Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

Chief Financial Officer

Chief Human Resources Officer

CSTO

Chief Scientific Officer

Chief Technical Officer

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease is under phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of Duchenne Muscular Dystrophy, which is under phase 1/2 clinical trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy is in phase 1/2 clinical trial. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-07	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-05-07	Premium	sold	Premium	Premium	Premium	President and CEO
2024-04-19	Premium	acquired	Premium	Premium	Premium	-
2024-04-19	Premium	sold	Premium	Premium	Premium	-
2024-04-03	Premium	sold	Premium	Premium	Premium	-
2024-04-02	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-04-02	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-19	Premium	sold	Premium	Premium	Premium	-
2024-03-19	Premium	acquired	Premium	Premium	Premium	-
2024-03-13	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-13	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-03-12	Premium	sold	Premium	Premium	Premium	-
2024-03-12	Premium	acquired	Premium	Premium	Premium	-
2024-03-12	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-12	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-08	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-08	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-01	Premium	sold	Premium	Premium	Premium	President and CEO
2024-01-22	Premium	sold	Premium	Premium	Premium	-
2024-01-22	Premium	sold	Premium	Premium	Premium	Chief Human Resources Officer
2024-01-22	Premium	sold	Premium	Premium	Premium	CSTO
2024-01-22	Premium	sold	Premium	Premium	Premium	President and CEO
2024-01-22	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-20	Premium	acquired	Premium	Premium	Premium	President and CEO

RNA - Avidity Biosciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for RNA